Filing Details
- Accession Number:
- 0001562180-21-001272
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-18 17:22:34
- Reporting Period:
- 2021-02-16
- Accepted Time:
- 2021-02-18 17:22:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578696 | David Davidson | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-16 | 10,000 | $0.00 | 46,298 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2021-02-16 | 2,271 | $0.00 | 48,569 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2021-02-17 | 698 | $28.16 | 47,871 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2021-02-16 | 20,000 | $0.00 | 20,000 | $28.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,000 | 2031-02-16 | No | 4 | A | Direct |
Footnotes
- Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/04/2022, 25% on 01/04/2023, 25% on 01/04/2024, and 25% on 01/04/2025.
- Immediately vested restricted stock unit reflecting the equity portion of the reporting person's 2020 performance compensation.
- Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- The range in prices for the transaction reported on this line was $27.97 to $28.54. The average weighted price was $28.1613. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This stock option vests over a four-year period at the rate of 25% on 01/04/2022 and then in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
